Whitbread PLC
25 November 2005
25 November 2005
Whitbread notes announcement of Britvic price range
Whitbread PLC ( 'Whitbread ' ) notes today's announcement from Britvic plc
('Britvic') regarding the offer price range of its initial public offering
(the 'Global Offer') and the publication of its price range prospectus.
Under the Global Offer, Whitbread, InterContinental Hotels Group and Pernod
Ricard ( the 'Selling Shareholders') will sell , on a pro rata basis , a
total of 153 million ordinary shares representing approximately 71% of the total
issued share capital of Britvic. In addition , the Selling Shareholders may sell
up to 22.9 million further shares in Britvic at the offer price under
over-allotment arrangements agreed with the underwriters. The number of shares
sold under the Global Offer may be increased or decreased.
At the announced price range of 210 pence to 250 pence per share and on the
basis of a 75% sell down of its 23.75% interest in Britvic, Whitbread would
receive gross proceeds of approximately £80.3million to £95.6million ( excluding
any shares sold under over-allotment arrangements ). The offer price may be set
within, above or below the offer price range. Full details of the Global Offer
can be found in the Britvic announcement and price range prospectus published
today.
It is expected that the precise number of shares to be sold in the Global Offer
and the offer price will be announced on or around 9 December 2005 and a further
announcement will be made when final proceeds have been determined.
In addition to the proceeds of sale it is expected that Whitbread will receive a
special dividend of £23.4million from Britvic on or about 29 November 2005. This
is in addition to the special dividend of £44.9 million paid in May 2005.
Enquiries:
Whitbread PLC:
Investor Queries:
Christopher Rogers Tel : 01582 396335
Media Enquiries:
Andrew Honnor
Tulchan Tel: 020 7353 4200
Anna Glover
Whitbread Tel : 01582 844244
The securities mentioned herein have not been , and will not be, registered
under the U.S. Securities Act of 1933 ( the 'Securities Act' ), and may not be
offered or sold in the United States ( as such term is defined in Regulation S
under the Securities Act) unless they are registered under the Securities Act or
pursuant to an exemption from registration.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.